Micreos appoints Matt Regan as CEO of its Pharmaceutical business

THE HAGUE, Netherlands, Oct. 14, 2021 /PRNewswire/ -- Dutch biotechnology company Micreos has recruited Matt Regan as CEO of its new Pharmaceutical business that will be based in Switzerland.

Related Keywords

Zurich ,Züsz ,Switzerland ,United States ,Netherlands ,Swiss ,Mark Offerhaus ,Kostenloser Wertpapierhandel ,Matt Regan ,Swiss Federal Technology Institute ,Novo Nordisk ,Atopic Dermatitis ,Cutaneoust Cell ,Diabetic Wound ,Micreos ,Ppoints ,Matt ,Megan ,Harmaceutical ,Business ,